Cytokinetics

CEO Robert I. Blum
USA | Funding: $1.8B (+)
Website: https://cytokinetics.com/
Cytokinetics develops first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised.
Website: https://cytokinetics.com/
Cytokinetics develops first-in-class muscle activators as potential treatments for debilitating diseases in which muscle performance is compromised.

